Evidence map›Paper›PMID 39027197›Full record

ArticleChronic diseases and translational medicine2024

Protocol for the development and validation of a clinical measurement tool for fear of disease progression and recurrence in cardiac patients.

Sarah T Clarke, Michael Le Grande, Barbara M Murphy, Robert Hester, Alun C Jackson

Registry-linked trialAbstract read
In one paragraph

Article in Chronic diseases and translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07444697 (Erectile Function After Percutaneous Coronary Intervention in Myocardial Infarction and Non-Infarction Patients), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07444697 recruitingnot on this mapstarted 2026, after this paper: background citation

Erectile Function After Percutaneous Coronary Intervention in Myocardial Infarction and Non-Infarction Patients: A Prospective Comparative Study.

Typeobservational_patient_registrySponsorKırıkkale UniversityRan2026 to 2026Enrolled100ConditionsErectile Disfunction, Coronary Artery Disease (CAD), Diabete Mellitus, Anxiety
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sarah T ClarkeMelbourne School of Psychological Sciences University of Melbourne Parkville Victoria Australia.ORCID 0000-0003-1908-1405
Michael Le GrandeMelbourne School of Psychological Sciences University of Melbourne Parkville Victoria Australia.
Barbara M MurphyMelbourne School of Psychological Sciences University of Melbourne Parkville Victoria Australia.
Robert HesterMelbourne School of Psychological Sciences University of Melbourne Parkville Victoria Australia.
Alun C JacksonMelbourne School of Psychological Sciences University of Melbourne Parkville Victoria Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: One in two cardiac patients fear having another heart event or their heart condition getting worse. Research in other chronic illnesses demonstrates that screening for fear of progression and recurrence is vital for adequately addressing such concerns in clinical care. The current project aims to develop and validate a measure for fear of progression and recurrence in cardiac patients. Methods: The Fear of Cardiac Recurrence and Progression Scale (FCRP) will be developed through a multistep process. An initial item pool will be generated through a review of the literature and existing measures and consultation with and feedback from key informants. The item pool will be tested in a sample of over 250 adults who have ever had an acute coronary event, undergone cardiac surgery, or a chronic cardiac condition. Exploratory factor analysis will be used to identify the underlying factors, and Rasch analysis will be used to reduce the number of items. A short form version of the FCRP will be developed for use as a brief screening tool, informed by clinical relevance and Rasch psychometric indices. Discussion: While many cardiac patients experience fears related to the progression or recurrence of their illness, there remains the need for a validated tool with which these concerns can be identified and measured. It is expected that the design and validation of the FCRP will aid identification of cardiac patients suffering from clinically significant levels of fear of progression and recurrence and facilitate the design of tailored psychological interventions to target these fears.

Indexed as

anxietycardiac anxietycardiac recoverycardiac rehabilitationdepressionfear of progressionfear of recurrencepsychological measurementpsychosocial screening

Identifiers

PMID39027197
PMCPMC11252435

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.